Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2012
03/08/2012WO2011036619A3 Two step ultrasound protocol for drug delivery
03/08/2012WO2011022199A8 Multi-layer transdermal patch
03/08/2012WO2011017483A8 Sublingual and buccal film compositions
03/08/2012WO2011006508A8 Adhesive patch with zonase
03/08/2012WO2011003602A3 Tableting agent having a low water content, and method for the production thereof
03/08/2012WO2010146591A3 Methods and devices for delivery of pharmaceutical agents within orifices of the body
03/08/2012WO2001000832A9 Methods for making apo-2 ligand using divalent metal ions
03/08/2012US20120059462 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
03/08/2012US20120059358 Dna vaccines encoding heat shock proteins
03/08/2012US20120059307 Compositions and Methods for Targeted Thermomodulation
03/08/2012US20120059240 Method for preparation of micellar hybrid nanoparticles for therapeutic and diagnostic applications and compositions thereof
03/08/2012US20120059148 Non-naturally occurring lipoprotein particle
03/08/2012US20120059066 Pharmaceutical salts
03/08/2012US20120058981 Androgen pharmaceutical composition and method for treating depression
03/08/2012US20120058979 Methods and reagents for the treatment of immunoinflammatory disorders
03/08/2012US20120058969 Cystitis treatment with high dose chondroitin sulfate
03/08/2012US20120058673 Coaxial connector having detachable locking sleeve
03/08/2012US20120058196 Pharmaceutical compositions of dextran polymer derivatives and a carrier material
03/08/2012US20120058195 Microencapsulation of bioactive substances and methods of making the same
03/08/2012US20120058194 Pharmaceutical formulations comprising substituted benzimidazole derivatives
03/08/2012US20120058193 Injectable smart gel and method for fabricating the same
03/08/2012US20120058191 Carbon-bearing nsp3 nanoparticle and its synthesis route
03/08/2012US20120058190 Food containing prolactin
03/08/2012US20120058189 Process for making a crystalline zilpaterol salt
03/08/2012US20120058188 Lipid encapsulated interfering rna
03/08/2012US20120058187 Water-in-oil type emulsion for treating a disease of the eye
03/08/2012US20120058186 Therapeutic or prophylactic agent for dyskinesia
03/08/2012US20120058185 Stable pharmaceutical compositions of olanzapine and process for their preparation
03/08/2012US20120058184 Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males
03/08/2012US20120058183 Retigabine tablets, preferably having modified release
03/08/2012US20120058182 Method and composition for administering an nmda receptor antagonist to a subject
03/08/2012US20120058181 Prebiotic Suppositories
03/08/2012US20120058180 Liver-specific Nanocapsules and Methods of Using
03/08/2012US20120058179 Apparatus and process for encapsulating microparticles with liquid in soft gel capsules
03/08/2012US20120058178 Liposome Composition
03/08/2012US20120058177 Nanoparticle-based tumor-targeted drug delivery
03/08/2012US20120058176 Controlled release delivery system for nasal applications and method of treatment
03/08/2012US20120058175 Transdermal Preparation
03/08/2012US20120058174 Fabrication of interconnected model vasculature
03/08/2012US20120058173 Selective starch feeding protocol
03/08/2012US20120058172 Plant extracts for use in brain modulation
03/08/2012US20120058171 Zoo-technical drug delivery device
03/08/2012US20120058170 Drug delivery by carbon nanotube arrays
03/08/2012US20120058167 Methods for treating scars and aging skin
03/08/2012US20120058164 Cleaning or cosmetic compositions comprising natural zeolites
03/08/2012US20120058163 Water-dispersible and multicomponent fibers from sulfopolyesters
03/08/2012US20120058162 Stable, spray dryed, immunogenic, viral compositions
03/08/2012US20120058161 Alkylated semi synthetic glycosaminoglycosan ethers, and methods for making and using thereof
03/08/2012US20120058160 Particulate materials
03/08/2012US20120058158 Sublingual Pharmaceutical Composition Comprising a Neutral Oil
03/08/2012US20120058157 Methods of Treating Cardiovascular Disorders Associated with Atherosclerosis
03/08/2012US20120058156 Activated leukocyte composition and uses for wound healing
03/08/2012US20120058155 Slow-degrading polymers for undelayed and sustained drug delivery
03/08/2012US20120058153 Synthetic nanocarrier vaccines comprising proteins obtained or derived from human influenza a virus hemagglutinin
03/08/2012US20120058152 Bone regeneration materials based on combinations of monetite and other bioactive calcium and silicon compounds
03/08/2012US20120058151 nanoparticulate compositions of poorly soluble compounds
03/08/2012US20120058150 Methods for Delivering Compositions by Electrospraying a Medical Device
03/08/2012US20120058057 Anti-dandruff Agents
03/08/2012US20120058056 Treatment of cutaneous hemangioma
03/08/2012US20120058055 Gastrorententive oral high dose zinc preparations
03/08/2012US20120058048 Directed radiotherapy
03/08/2012US20120055780 Polysaccharide pseudo-sponge
03/08/2012US20120055469 Stable pharmaceutical drug products
03/08/2012DE102010040299A1 Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner) Transdermal therapeutic systems having crystallization protective film (release liner)
03/08/2012DE102006049929B4 Filmbildende Gelkomposition zur Wund- bzw. Hautpflege The film-forming gel composition for wound and skin care
03/08/2012CA2812044A1 Methods of treating bacterial infections through pulmonary delivery of fusidic acid
03/08/2012CA2809934A1 Process for producing drug-block copolymer composite and pharmaceutical preparation containing same
03/08/2012CA2809863A1 Lipids suitable for liposomal delivery of protein-coding rna
03/08/2012CA2809851A1 Pegylated liposomes for delivery of immunogen-encoding rna
03/08/2012CA2809835A1 Hemostatic compositions and methods of making and using same
03/08/2012CA2809700A1 Adenosine a1 agonists for the treatment of glaucoma and ocular hypertension
03/08/2012CA2809678A1 Small liposomes for delivery of immunogen-encoding rna
03/08/2012CA2809677A1 Anti-c-met antibody and methods of use thereof
03/08/2012CA2809666A1 Dry powder formulations and methods for treating pulmonary diseases
03/08/2012CA2809617A1 Nanoparticle-based tumor-targeted drug delivery
03/08/2012CA2809460A1 A water-in-oil type emulsion for treating a disease of the eye
03/08/2012CA2808988A1 Tamper resistant dosage form comprising an anionic polymer
03/08/2012CA2808912A1 Modified-release dosage forms of 5-ht2c agonists useful for weight management
03/08/2012CA2808541A1 Tamper resistant dosage form comprising an anionic polymer
03/08/2012CA2808219A1 Tamper resistant dosage form comprising inorganic salt
03/08/2012CA2808170A1 Mesalazine tablet having improved dissolution
03/08/2012CA2807448A1 Tetranectin-apolipoprotein a-i, lipid particles containing it and its use
03/08/2012CA2807441A1 Method for producing a lipid particle, the lipid particle itself and its use
03/08/2012CA2807433A1 Method for producing a lipid particle, the lipid particle itself and its use
03/08/2012CA2803052A1 Coating agent for pharmaceutical solid preparation, pharmaceutical film formulation, and coated pharmaceutical solid preparation
03/07/2012EP2425859A1 Olmesartan formulations
03/07/2012EP2425842A1 Composition for symptomatic local treatment of the nasal mucous membrane and nose drops containing this composition
03/07/2012EP2425829A1 Soluble pharmaceutical forms of n,n'-diaminodiphenyl sulphone for optimum use in the treatment of various diseases
03/07/2012EP2425828A2 Films for delivery of a therapeutic agent
03/07/2012EP2425827A1 Transdermal preparation
03/07/2012EP2425826A1 Mesalazine tablet having improved dissolution
03/07/2012EP2425825A1 Pharmaceutical preparation containing oxycodone and naloxone
03/07/2012EP2425824A1 Pharmaceutical preparation containing oxycodone and naloxone
03/07/2012EP2425823A1 Pharmaceutical preparation containing oxycodone and naloxone
03/07/2012EP2425822A1 Sustained release tablets with hydromorphone
03/07/2012EP2425821A1 Pharmaceutical preparation containing oxycodone and naloxone
03/07/2012EP2425820A1 Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
03/07/2012EP2425819A1 Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
03/07/2012EP2425818A1 Self micro-emulsifying oral pharmaceutical composition of hydrophilic drug and preparation method thereof
03/07/2012EP2425817A1 Polymerized micelles for diagnosis
1 ... 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 ... 2991